Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1994
website : www.tianyuanbio.com
Main Product : Heparin Sodium, Enoxaparin Sodium, Hyaluronic Acid
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a reputable pharmaceutical company founded in 1994. They specialize in the production of heparin products, enoxaparin sodium, and hyaluronic acid. With a strong presence in both domestic and international markets, the company is known for its high-quality products and competitive pricing.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : 2003
website : www.bchtbiotech.com
Main Product : Biopharmaceuticals, vaccines, diagnostic reagents
Company Profile
Changchun BCHT Biotechnology Co., Ltd. is a leading biotechnology company specializing in the development and production of biopharmaceuticals, vaccines, and diagnostic reagents. With a focus on research and innovation, the company has established itself as a key player in the global biotechnology industry, serving markets in China, Asia, Europe, and North America.
Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1948
website : http://www.cibp.cnic.cn/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a renowned company specializing in the research, development, and production of vaccines and biological products. Established in 1948, the company has grown to become a key player in the industry, with a large market share in China and a strong presence in international markets. With a commitment to innovation and quality, the company continues to be a leader in the field of biological products.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : Chengdu Institute of Biological Products Co., Ltd. was established in 1969.
website : http://www.cibp.com.cn/.
Main Product : Its main products include vaccines and biological products.
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is dedicated to providing high-quality vaccines and biological products to customers worldwide.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1965.
website :
Main Product : They have a large company size and a strong presence in the market.
Company Profile
Their website is http://www.whb.com.cn/ for more information.
